Watch Dr. Wayne Winegarden Explain the Impact of Upcoming Biologics Regulatory Reform
March 26, 2020
Watch Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, discuss the issues and benefits of the FDA’s switch to a biologics regulatory pathway for certain products, especially insulin, during the World Biosimilar Congress USA 2020 at the Festival of Biologics USA in San Diego, California.